Gao Xueqin, Wright Nathaniel, Huard Matthieu, Tan Jian, Ruzbarsky Joseph, Lu Aiping, Chubb Laura, Tuan Rocky, Philippon Marc J, Wang Yadong, Huard Johnny
Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, 81657, USA.
Meinig School of Biomedical Engineering, Cornell, University, Ithaca, NY 14853, USA.
Bioact Mater. 2025 Jun 19;52:588-603. doi: 10.1016/j.bioactmat.2025.06.031. eCollection 2025 Oct.
Cartilage defect repair and osteoarthritis treatments remain clinical challenges. Microfracture is a commonly used surgical procedure for the treatment of cartilage defects but often leads to fibrocartilage repair. The aim of this study is to compare the effects of 5 bone morphogenetic proteins (BMPs) on chondrogenic differentiation of human bone marrow mesenchymal stem cells, as well as to investigate the use of the heparin/poly (ethylene arginine aspartate diglyceride (PEAD) coacervate sustained release system to deliver these BMPs for microfracture-mediated cartilage repair. Our results indicate that all 5 human BMPs significantly enhance the chondrogenic differentiation of human bone marrow mesenchymal stem cells (hBMMSCs) with BMPs 2,4 and 9 being more potent than BMP6 or BMP7, as revealed by Alcian blue, SO staining, and immunohistochemistry of COL2. Coacervate-BMPs are biocompatible for both hBMMSCs and rat muscle-derived stem cells (MDSCs) and promote their proliferation. , sustained release of human BMPs 2,4,6,7,9 with heparin/PEAD coacervate significantly enhances microfracture-mediated cartilage repair in a rat osteochondral defect model, as demonstrated by ICRS macroscopic score, Seller's histology score, and COL2 staining. These effects are mediated by increasing SOX9 expression in the regenerated cartilage. In conclusion, BMPs 2,4,9 are the most potent BMPS to promote chondrogenic differentiation, while all BMPs enhanced microfracture-mediated cartilage repair when delivered with heparin/PEAD coacervate without a significant difference between the different BMPs.
软骨缺损修复和骨关节炎治疗仍然是临床难题。微骨折术是治疗软骨缺损常用的外科手术,但常导致纤维软骨修复。本研究旨在比较5种骨形态发生蛋白(BMPs)对人骨髓间充质干细胞软骨分化的影响,并研究使用肝素/聚(天冬氨酸二甘油酯精氨酸乙酯)(PEAD)凝聚层缓释系统递送这些BMPs用于微骨折介导的软骨修复。我们的结果表明,所有5种人BMPs均显著增强人骨髓间充质干细胞(hBMMSCs)的软骨分化,阿尔新蓝、SO染色和Ⅱ型胶原蛋白免疫组化显示,BMP2、4和9比BMP6或BMP7更有效。凝聚层-BMPs对hBMMSCs和大鼠肌肉来源干细胞(MDSCs)均具有生物相容性,并促进其增殖。肝素/PEAD凝聚层对人BMP2、4、6、7、9的缓释在大鼠骨软骨缺损模型中显著增强了微骨折介导的软骨修复,这通过国际软骨修复协会(ICRS)宏观评分、塞勒组织学评分和Ⅱ型胶原蛋白染色得以证明。这些作用是通过增加再生软骨中SOX9的表达来介导的。总之,BMP2、4、9是促进软骨分化最有效的BMPs,而所有BMPs与肝素/PEAD凝聚层一起递送时均增强了微骨折介导的软骨修复,不同BMPs之间无显著差异。